EUVIMEDEUVIMED entdecken
Crossref

PUM1 enhances PAK6 mRNA stability and contributes to growth and ferroptosis resistance in lung adenocarcinoma cells

Jing Zhang, Yang Li, Xin Shi, Haixia Wang, Xiangyu Su, Xuejun He

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Jing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Taizhou Second People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu 225300, China. Hauptthemen laut MEDLINE: Ferroptosis, p21-Activated Kinases, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer and a major contributor to cancer-related mortality. This study investigates the role of p21 (RAC1)-activated kinase 6 (PAK6) in LUAD progression, with a focus on its involvement in modulating resistance to ferroptosis. METHODS: GEO datasets were analyzed to identify genes with altered expression in LUAD. Loss-of-function assays were conducted in human LUAD cell lines to assess the effects of PAK6 depletion on cell viability, proliferation, and cell death. Ferroptosis sensitivity was evaluated by measuring levels of ferrous iron (Fe2 +) and malondialdehyde (MDA). The interaction between PAK6 and pumilio RNA-binding family member 1 (PUM1) was assessed using RNA immunoprecipitation and luciferase assays. For in vivo verification, mouse LA795 LUAD cells were implanted into nude mice. RESULTS: Bioinformatics analysis revealed that PAK6 is upregulated in LUAD. Increased immunofluorescence staining and mRNA expression of PAK6 were confirmed in human LUAD cell lines. Loss of PAK6 inhibited the proliferation and migration of LUAD cells in vitro while promoting cell death. However, ferroptosis inhibition reduced cell death. Furthermore, PAK6 silencing elevated Fe2+ and MDA levels, and enhanced the anti-tumor effects of the ferroptosis inducer Erastin. PUM1, which is upregulated in LUAD, binds to PAK6 and stabilizes its RNA. Silencing PUM1 promoted ferroptosis both in vitro and in animal models, an effect that was reversed by artificial restoration of PAK6. CONCLUSION: This study demonstrates that PUM1 enhances the RNA stability of PAK6, thereby contributing to ferroptosis resistance in LUAD cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ferroptosisp21-Activated KinasesAdenocarcinoma of LungLung NeoplasmsRNA-Binding ProteinsRNA StabilityHumansAnimalsCell ProliferationMiceGene Expression Regulation, NeoplasticMice, NudeCell Line, Tumor

Stichwörter der Autor:innen

FerroptosisLUADPAK6PUM1RNA stabilization

Substanzen

p21-Activated KinasesRNA-Binding ProteinsPUM1 protein, humanPAK6 protein, human

Autor:innen und Institutionen

  • Department of Oncology, Taizhou Second People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu 225300, China.
  • Department of Oncology, Zhongda Hospital, Southeast University, Nanjin, Jiangsu 210009, China.
  • Department of Oncology, Taizhou Second People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu 225300, China. Electronic address: Hexuejun1975@163.com.

Zitieren

APA

Zhang, J., Li, Y., Shi, X., Wang, H., Su, X., & He, X. (2025). PUM1 enhances PAK6 mRNA stability and contributes to growth and ferroptosis resistance in lung adenocarcinoma cells. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156094

Vancouver

Zhang J, Li Y, Shi X, Wang H, Su X, He X. PUM1 enhances PAK6 mRNA stability and contributes to growth and ferroptosis resistance in lung adenocarcinoma cells. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156094

BibTeX
@article{Zhang2025,
  author = {Zhang, Jing and Li, Yang and Shi, Xin and Wang, Haixia and Su, Xiangyu and He, Xuejun},
  title = {PUM1 enhances PAK6 mRNA stability and contributes to growth and ferroptosis resistance in lung adenocarcinoma cells},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156094}
}
Kostenlos starten →